Comment on 'Impact of CYP2D6*10 on recurrence-free survival in breast cancer patients receiving adjuvant tamoxifen therapy'

Cancer Sci. 2008 Aug;99(8):1706-7. doi: 10.1111/j.1349-7006.2008.00864.x.
No abstract available

Publication types

  • Comment
  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alleles
  • Antineoplastic Agents, Hormonal / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Chemotherapy, Adjuvant
  • Cytochrome P-450 CYP2D6 / genetics*
  • Disease-Free Survival
  • Female
  • Gene Frequency*
  • Genotype
  • Humans
  • Neoplasm Recurrence, Local
  • Tamoxifen / therapeutic use*

Substances

  • Antineoplastic Agents, Hormonal
  • Tamoxifen
  • Cytochrome P-450 CYP2D6